Immune Checkpoint Inhibitor-Based Therapy as a Backbone in Cancer Treatment

K. M. Rubin, A. J. Olszanski

Research output: Contribution to journalArticlepeer-review

Abstract

At JADPRO Live 2019, Krista M. Rubin, MS, FNP-BC, and Anthony J. Olszanski, MD, RPh, reviewed the basic concepts of immunotherapy and the current treatment landscape, and discussed emerging data for immune checkpoint inhibitor-based combinations that are being explored in late- stage clinical trials.
Original languageEnglish
Pages (from-to)231-233
Number of pages3
JournalJournal of the advanced practitioner in oncology
Volume11
Issue number3
DOIs
StatePublished - 2020

Fingerprint

Dive into the research topics of 'Immune Checkpoint Inhibitor-Based Therapy as a Backbone in Cancer Treatment'. Together they form a unique fingerprint.

Cite this